INZY
Price
$0.93
Change
+$0.06 (+6.90%)
Updated
Apr 2 closing price
Capitalization
59.51M
40 days until earnings call
KROS
Price
$10.04
Change
+$0.49 (+5.13%)
Updated
Apr 2 closing price
Capitalization
407.24M
28 days until earnings call
Ad is loading...

INZY vs KROS

Header iconINZY vs KROS Comparison
Open Charts INZY vs KROSBanner chart's image
Inozyme Pharma
Price$0.93
Change+$0.06 (+6.90%)
Volume$379.48K
Capitalization59.51M
Keros Therapeutics
Price$10.04
Change+$0.49 (+5.13%)
Volume$1.15M
Capitalization407.24M
INZY vs KROS Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. KROS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and KROS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (INZY: $0.87 vs. KROS: $9.55)
Brand notoriety: INZY and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 77% vs. KROS: 125%
Market capitalization -- INZY: $59.51M vs. KROS: $407.24M
INZY [@Biotechnology] is valued at $59.51M. KROS’s [@Biotechnology] market capitalization is $407.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whileKROS’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • KROS’s FA Score: 0 green, 5 red.
According to our system of comparison, both INZY and KROS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while KROS’s TA Score has 5 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 2 bearish.
  • KROS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, INZY is a better buy in the short-term than KROS.

Price Growth

INZY (@Biotechnology) experienced а -10.41% price change this week, while KROS (@Biotechnology) price change was -15.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

INZY is expected to report earnings on May 13, 2025.

KROS is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($407M) has a higher market cap than INZY($59.5M). KROS YTD gains are higher at: -36.576 vs. INZY (-66.556). INZY has higher annual earnings (EBITDA): -95.72M vs. KROS (-185.82M). KROS has more cash in the bank: 560M vs. INZY (113M). KROS has less debt than INZY: KROS (18.9M) vs INZY (46.9M). KROS has higher revenues than INZY: KROS (3.55M) vs INZY (0).
INZYKROSINZY / KROS
Capitalization59.5M407M15%
EBITDA-95.72M-185.82M52%
Gain YTD-66.556-36.576182%
P/E RatioN/AN/A-
Revenue03.55M-
Total Cash113M560M20%
Total Debt46.9M18.9M248%
TECHNICAL ANALYSIS
Technical Analysis
INZYKROS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEXN8.900.39
+4.58%
Nexxen International Ltd
IAG6.470.15
+2.37%
IAMGold Corp
SQNS2.120.03
+1.44%
Sequans Communications S.A.
HRB56.650.32
+0.57%
H&R Block
MUFG13.22-0.08
-0.60%
Mitsubishi UFJ Financial Group

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+6.48%
IGMS - INZY
52%
Loosely correlated
+6.96%
MRSN - INZY
50%
Loosely correlated
+1.68%
CRNX - INZY
48%
Loosely correlated
+2.51%
DYN - INZY
48%
Loosely correlated
+7.37%
APGE - INZY
46%
Loosely correlated
+6.23%
More

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INZY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+5.13%
INZY - KROS
43%
Loosely correlated
+6.48%
AXON - KROS
43%
Loosely correlated
+3.18%
RAPT - KROS
39%
Loosely correlated
-0.85%
DNLI - KROS
39%
Loosely correlated
+11.80%
VERV - KROS
39%
Loosely correlated
-5.44%
More